Related Experiment Video

Updated: Aug 7, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Pharmacotherapy of lupus nephritis in children: a recommended treatment approach

Alexa Adams1, Emma Jane MacDermott, Thomas J A Lehman

  • 1Division of Pediatric Rheumatology, Hospital for Special Surgery, New York, NY 10021, USA.

Drugs
|July 11, 2006
PubMed

Insights

Systemic lupus erythematosus (SLE) nephritis in children requires effective treatment. Current standards focus on cyclophosphamide, with newer agents like rituximab showing promise for improved outcomes.

Area of Science:

  • Pediatric Rheumatology
  • Nephrology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is a multisystem inflammatory disease with recurrent flares.
  • Renal involvement (lupus nephritis) is a major cause of morbidity and mortality in pediatric SLE.
  • Lupus nephritis presents a spectrum from mild glomerulitis to severe proliferative glomerulonephritis.

Purpose of the Study:

  • To review current standards of care for pediatric lupus nephritis.
  • To discuss newer and emerging therapies for this condition.
  • To provide guidelines for comprehensive care of children with lupus nephritis.

Main Methods:

  • Review of current literature on SLE and lupus nephritis treatment in children.
  • Analysis of established and investigational therapeutic agents.
  • Discussion of clinical guidelines and expert recommendations.

Main Results:

  • Corticosteroids are first-line but often supplemented by cytotoxic drugs like cyclophosphamide.
  • Mycophenolate mofetil shows less efficacy in children compared to adults.
  • Intravenous cyclophosphamide is the standard for highly active pediatric lupus nephritis.
  • Rituximab may aid remission induction and reduce cyclophosphamide dosage.

Conclusions:

  • Combination therapies and novel agents hold future promise for pediatric lupus nephritis.
  • Understanding SLE immune dysregulation is key to developing better treatments.
  • Evidence-based guidelines are essential for optimal management and comprehensive care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...